Abstract
Quantitative structure–activity relationship studies have been performed on twenty one β-carboline derivatives to investigate the structural requirements for antitumor activity. The best 2D-QSAR model (r2 = 0.802, F = 24.321, r2se = 0.325) indicated statistical significance and internal predictivity of the developed model shown by the value of cross validated squared correlation coefficient which was 0.724. A five-point pharmacophore hypothesis yielded ligand based pharmacophore 3D-QSAR models with good partial least-square (PLS) statistics results. The training set and test set correlation was characterized by PLS factors (r 2 = 0.842, SD = 0.306, F = 21.3, P = 4.27e -05, Q2 ext = 0.748, RMSE = 0.531, Pearson-R = 0.975). A docking study revealed the binding orientations of DNA intercalates at active site of amino acid residues. The results of 2D-QSAR and 3D-QSAR give detailed structural insights and at the same time highlight the important binding features of novel β-carboline derivatives as antitumor agents.
Keywords: β-carboline, Antitumor, Pharmacophore, 2D-QSAR, 3D-QSAR, Docking.
Letters in Drug Design & Discovery
Title:Pharmacophore Modeling and QSAR Analysis of Novel β-carboline Derivatives as Antitumor Agents
Volume: 10 Issue: 7
Author(s): Ravindra Kumar Chourasiya, A. Raghuram Rao and Ram Kishore Agrawal
Affiliation:
Keywords: β-carboline, Antitumor, Pharmacophore, 2D-QSAR, 3D-QSAR, Docking.
Abstract: Quantitative structure–activity relationship studies have been performed on twenty one β-carboline derivatives to investigate the structural requirements for antitumor activity. The best 2D-QSAR model (r2 = 0.802, F = 24.321, r2se = 0.325) indicated statistical significance and internal predictivity of the developed model shown by the value of cross validated squared correlation coefficient which was 0.724. A five-point pharmacophore hypothesis yielded ligand based pharmacophore 3D-QSAR models with good partial least-square (PLS) statistics results. The training set and test set correlation was characterized by PLS factors (r 2 = 0.842, SD = 0.306, F = 21.3, P = 4.27e -05, Q2 ext = 0.748, RMSE = 0.531, Pearson-R = 0.975). A docking study revealed the binding orientations of DNA intercalates at active site of amino acid residues. The results of 2D-QSAR and 3D-QSAR give detailed structural insights and at the same time highlight the important binding features of novel β-carboline derivatives as antitumor agents.
Export Options
About this article
Cite this article as:
Chourasiya Kumar Ravindra, Rao Raghuram A. and Agrawal Kishore Ram, Pharmacophore Modeling and QSAR Analysis of Novel β-carboline Derivatives as Antitumor Agents, Letters in Drug Design & Discovery 2013; 10 (7) . https://dx.doi.org/10.2174/1570180811310070004
DOI https://dx.doi.org/10.2174/1570180811310070004 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Polymeric Nano-Assemblies as Emerging Delivery Carriers for Therapeutic Applications: A Review of Recent Patents
Recent Patents on Nanotechnology Armed Imidazo [1,2-a] Pyrimidines (Pyridines): Evaluation of Antibacterial Activity
Letters in Drug Design & Discovery Tripterine: A Potential Anti-Allergic Compound
Current Pharmaceutical Biotechnology Leukotriene C4 Synthase: Upcoming Drug Target For Inflammation
Current Drug Targets Ribonucleases: From Prototypes to Therapeutic Targets? (General Articles)
Current Medicinal Chemistry Triphenyl Phosphite-mediated “Green” Synthesis of Novel Carboxycoumarin Amides
Current Green Chemistry Nucleotide Second Messenger Signaling as a Target for the Control of Bacterial Biofilm Formation
Current Topics in Medicinal Chemistry Studies on Chemistry, Spectroscopy and Antioxidant Activities of Chromium(III)-Hydrazide Complexes
Medicinal Chemistry Periostin as a Heterofunctional Regulator of Cardiac Development and Disease
Current Genomics Design of New Oxazaphosphorine Anticancer Drugs
Current Pharmaceutical Design The COVID-19 and Munchausen Syndrome
Coronaviruses Exploring Mode of Phosphoramidon and Aβ Peptide Binding to hECE-1 by Molecular Dynamics and Docking Studies
Protein & Peptide Letters Synthesis of Pseudopeptides Derived from (R,R)-Tartaric Acid as Potential Inhibitors of HIV-Protease
Letters in Organic Chemistry Developments in Antiviral Drug Design, Discovery and Development in 2004
Current Drug Targets - Infectious Disorders Patent Review
Combinatorial Chemistry & High Throughput Screening New Adamantyl Chalcones: Synthesis, Antimicrobial and Anticancer Activities
Current Topics in Medicinal Chemistry Mutant B-Raf Kinase Inhibitors as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Non-Steroidal FXR Antagonists Development for Therapeutic Applications
Current Topics in Medicinal Chemistry Drug Targets in Infections with Other Emerging Viruses: Influenza Viruses, Metapneumovirus and Hantaviruses
Infectious Disorders - Drug Targets Serum Endocan, Neuron-Specific Enolase and Ischemia-Modified Albumin Levels in Newborns with Partial Blood Exchange Transfusion
Combinatorial Chemistry & High Throughput Screening